MeVis cuts FY 2025/26 revenue forecast to EUR 15-15.5 million from EUR 16.5-17 million

By Public Technologies
  • MeVis cut FY 2025/2026 guidance on preliminary results, projecting revenue of EUR 15.0 million to EUR 15.5 million.
  • Previous revenue outlook was EUR 16.5 million to EUR 17.0 million.
  • EBIT forecast shifted to a loss of EUR 1.0 million to EUR 1.5 million, versus prior profit of EUR 0.5 million to EUR 1.0 million.
  • Shortfall tied to weaker mammography demand at customer Hologic, slower rollout of lung cancer screening in Germany.
  • Outlook assumes a stable exchange rate of 1.16 USD/EUR.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeVis Medical Solutions AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2406544_de) on September 28, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk